{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=188109&min-date=2014-10-21&min-ddpCreated=2018-11-05T22%3A15%3A59.583Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=188109&min-date=2014-10-21&min-ddpCreated=2018-11-05T22%3A15%3A59.583Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=188109&min-date=2014-10-21&min-ddpCreated=2018-11-05T22%3A15%3A59.583Z&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=188109&_page=0&min-date=2014-10-21&min-ddpCreated=2018-11-05T22%3A15%3A59.583Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=188109&min-date=2014-10-21&min-ddpCreated=2018-11-05T22%3A15%3A59.583Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=188109&min-date=2014-10-21&min-ddpCreated=2018-11-05T22%3A15%3A59.583Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1642252", "AnsweringBody" : [{"_value" : "Home Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1642252/answer", "answerText" : {"_value" : "<p>The Government is engaging with the relevant companies to urgently determine a way forward on legacy licences.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4462", "label" : {"_value" : "Biography information for Tom Tugendhat"}
        }
        , "answeringMemberConstituency" : {"_value" : "Tonbridge and Malling"}
        , "answeringMemberPrinted" : {"_value" : "Tom Tugendhat"}
        , "dateOfAnswer" : {"_value" : "2023-06-13", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-06-13T14:37:24.37Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "1"}
      , "answeringDeptShortName" : {"_value" : "Home Office"}
      , "answeringDeptSortName" : {"_value" : "Home Office"}
      , "date" : {"_value" : "2023-06-06", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Animal Experiments: Cosmetics"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for the Home Department, whether she is taking steps to revoke existing licenses which allow companies to test exclusive-use cosmetics ingredients on animals.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4653", "label" : {"_value" : "Biography information for Stephen Morgan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Portsmouth South"}
      , "tablingMemberPrinted" : [{"_value" : "Stephen Morgan"}
      ], "uin" : "188109"}
    , {"_about" : "http://data.parliament.uk/resources/1312307", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1312307/answer", "answerText" : {"_value" : "<p>For the vast majority of people, COVID-19 induces a robust antibody response to natural infection within three weeks, which persists through to around three to six months. People with recent COVID-19 infection experience greater antibody levels following one dose of vaccine than those without recent infection. Work is ongoing to determine whether antibodies generated against currently prevalent COVID-19 variants will also protect against new variants. The correlate of protection for COVID-19 is not known yet, but evidence to date suggests that the levels of antibody strongly correlate with protection against future infections.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2021-04-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-04-29T12:02:16.31Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-04-27", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Disease Control"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the correlation between covid-19 infection and an increase in antibodies after contracting that virus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "188109"}
    , {"_about" : "http://data.parliament.uk/resources/1001907", "AnsweringBody" : [{"_value" : "Northern Ireland Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1001907/answer", "answerText" : {"_value" : "<p>This is a devolved issue. Northern Ireland Office officials have been liaising with the Northern Ireland Department of Health on this important issue and I am pleased to hear that work is ongoing to ensure an appropriate process is in place which will provide clinical consultants, and hence patients, access as soon as possible.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1496", "label" : {"_value" : "Biography information for Shailesh Vara"}
        }
        , "answeringMemberConstituency" : {"_value" : "North West Cambridgeshire"}
        , "answeringMemberPrinted" : {"_value" : "Mr Shailesh Vara"}
        , "dateOfAnswer" : {"_value" : "2018-11-13", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-11-13T15:48:42.6Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "21"}
      , "answeringDeptShortName" : {"_value" : "Northern Ireland"}
      , "answeringDeptSortName" : {"_value" : "Northern Ireland"}
      , "date" : {"_value" : "2018-11-05", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cancer: Northern Ireland"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Northern Ireland, with reference to the Department of Health in Northern Ireland (DHNI)\u2019s press release entitled Department Announces Improved Access to New Drugs, published on 12 September 2018, what discussions she has had with the DHNI on the timeline for providing access to medicines approved for use through the Cancer Drug Fund in England; and if she will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
      }
      , "tablingMemberConstituency" : {"_value" : "Strangford"}
      , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
      ], "uin" : "188109"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}